Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Chrissy Cochran

Chrissy Cochran

USFDA USA

Brian Edwards

Brian Edwards

NDA Regulatory Science limited UK

Alexey Skripkin

Alexey Skripkin

BIOCAD Russia

Cristina Damatarca MD

Cristina Damatarca MD

Agility Clinical USA

Nathan Cummins MD

Nathan Cummins MD

Mayoclinic USA

Eugenia Hong

Eugenia Hong

The Royal Melbourne Hospital Australia

Silvia Cacho-Elizondo

Silvia Cacho-Elizondo

IPADE Business School USA

Mario Bertazzoli

Mario Bertazzoli

Helsinn Healthcare SA Switzerland

Pharmacoepidemiology congress

Sessions/Tracks

ConferenceSeries Ltd is delighted and cordially welcomes you to attend the  splendorous 11th International Conference on Pharmacoepidemiology and Clinical researchJuly 06-08, 2017 at Kuala Lumpur, Malaysia.

Experts Meeting to join the Global scientific influencers from  Asia, Middleeast, Europe, USA(America) and Africa at Pharmacoepidemiology and Clinical research Congress, organised at Kuala Lumpur, Malaysia from July 06-08, 2017 with a main theme “Advanced Clinical research and compliance in Pharmacoepidemiologic studies in the arena of Pharmacoepidemiology”.

Pharmacoepidemiology congress includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and extensive networking and B2B interactions.

 Track 1: Pharmacoepidemiology and Clinical Research :

Pharmacoepidemiology  is a broad science involving uses and effects of drugs in larger domains of population. Pharmacoepidemiology is a bridging science spanning both pharmacology and epidemiology enhancing the informative study on topics apparently related to Pharmacoepidemiology, Pharmacokinetics, Adverse drug reactions, Public health, Epidemiologic methods, Medication adherence and Drug safety. This topic serves as a unique forum dedicated to scientists to express their findings as research presentations on an array of Pharmacoepidemiology and Drug Safety. The aims of pharmacoepidemiology within the industry are essentially the same as those of pharmacovigilance regulatory agencies; that is to protect patients from unnecessary medication hazards by identifying the adverse effects, elucidating pre-disposing factors, refuting false safety signals and quantifying risk in relation to benefit. Clinical research  is a branch of health care science that enables the use of various medications, clinical therapeutics, medical and clinical devices, equipments and medical products for diagnosis, and treatment regimens used for the treatment of human disorders and diseases and patient safety.

Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events

8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 8th World Congress on Toxicology and Pharmacology April 13-15, 2017 Dubai, UAE; World Heart Congress May 22-24, 2017 Osaka, Japan; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala lumpur, Malaysia; 8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; April 27 - 28, 2017; 19th International Conference on Pharmacoepidemiology and Pharmacogenetics January 8 - 9, 2017,Singapore : 19th International Conference on Pharmaceutical Preformulation and Pharmacoepidemiology November 24 - 25, 2017 , Dubai, UAE.

Related Associations or Societies:

International Society for Pharmacoepidemiology, Center for Drug Safety and Effectiveness,  Center for Public Health and Human Rights, Center  for Health Services  and Outcomes Research, International Pharmaceutical Federation, International Society of Pharmacovigilance

Track 2: Clinical Pharmacology and Therapeutics :

Clinical pharmacology is the science dealing with drugs and their clinical use. It is underpinned by the basic science of pharmacology, with added focus on the application of pharmacological principles and quantitative methods in the real world. It has a broad scope, from the discovery of new target molecules, to the effects of drug usage in whole populations. Clinical pharmacology connects medical and pharmacy practices with laboratory sciences. Clinical pharmacological studies are conducted to increase the drug efficacy,  promote the safety of prescription, and minimise the side effects.

Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events

8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 8th World Congress on Toxicology and Pharmacology April 13-15, 2017 Dubai, UAE; World Heart Congress May 22-24, 2017 Osaka, Japan; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala lumpur, Malaysia; 8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; April 27 - 28, 2017; 19th International Conference on Pharmacoepidemiology and Pharmacogenetics January 8 - 9, 2017, Singapore : 19th International Conference on Pharmaceutical Preformulation and Pharmacoepidemiology November 24 - 25, 2017 , Dubai, UAE.

Related Associations or Societies:

Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research AssociatesClinical Research Society, American Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry .

Track 3: Pre-Clinical and Clinical Trials :

Preclinical trials involves the assessment of  potential therapeutic interventions in cells and animals. Clinical trials are the distinct procedures followed in development of new drugs. Clinical trials are the characteristic  studies intended for the treatment of  behavioral symptoms between a medical intervention and a health outcome. Clinical trials includes patient data, disease mechanisms, therapeutic interventions, epidemiology, clinical medicine, preclinical and clinical pharmacology, immunology, toxicological studies. Clinical trials involves experimental trials and observational studies.Clinical data is a key feature transforming basic research into medical care. The perfect outcome of clinical trials is minimize risks, extend benefits, and optimal use of an intervention of therapeutic drugs.

Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events

8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 8th World Congress on Toxicology and Pharmacology April 13-15, 2017 Dubai, UAE; World Heart Congress May 22-24, 2017 Osaka, Japan; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala lumpur, Malaysia; 8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; April 27 - 28, 2017; 19th International Conference on Pharmacoepidemiology and Pharmacogenetics January 8 - 9, 2017, Singapore : 19th International Conference on Pharmaceutical Preformulation and Pharmacoepidemiology November 24 - 25, 2017 , Dubai, UAE.

Related Associations or Societies:

International Society for Pharmacoepidemiology, Center for Drug Safety and Effectiveness,  Center for Public Health and Human Rights, Center  for Health Services  and Outcomes Research, International Pharmaceutical Federation, International Society of Pharmacovigilance .

Track 4: Clinical Drug Development :

A clinical drug development is an experiment conducted on human subjects  to test the improvement of medical treatments .The entire procedure of this theoretical science or formal study of clinical trials , planning and analysis of experiments, surveys, and observational studies is guided by statistical analysis. Statistical analysis in clinical trials help in establishing an objective framework for conducting an investigation by placing data and theory on an equal scientific footing and designing clinical data production through experimentation and quantifying the influence of chance and also to estimate the systematic and random effects.

Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events

8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 8th World Congress on Toxicology and Pharmacology April 13-15, 2017 Dubai, UAE; World Heart Congress May 22-24, 2017 Osaka, Japan; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala lumpur, Malaysia; 8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; April 27 - 28, 2017; 19th International Conference on Pharmacoepidemiology and Pharmacogenetics January 8 - 9, 2017,Singapore : 19th International Conference on Pharmaceutical Preformulation and Pharmacoepidemiology November 24 - 25, 2017 , Dubai, UAE.

Related Associations or Societies:

Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research AssociatesClinical Research Society, American Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry .

Track 5: Drug Safety and Pharmacotherapy :

Drug Safety is the pharmacological science ensuring safety and related to the collection, detection, assessment, monitoring, and prevention of adverse side effects with pharmaceutical products. Pharmacotherapy or drug therapy is  using  a medication to treat disease. Drugs interact with receptors or enzymes in cells to promote healthy functioning and reduce or cure illness. It is employed to treat a range of behavioural symptoms, disorders and diseases. Safety monitoring in clinical trials involves collecting adverse events, laboratory investigations including the planning, execution, data analysis and reporting of safety information and details of the clinical examination of patients.

Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events

8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 8th World Congress on Toxicology and Pharmacology April 13-15, 2017 Dubai, UAE; World Heart Congress May 22-24, 2017 Osaka, Japan; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala lumpur, Malaysia; 8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; April 27 - 28, 2017; 19th International Conference on Pharmacoepidemiology and Pharmacogenetics January 8 - 9, 2017,Singapore : 19th International Conference on Pharmaceutical Preformulation and Pharmacoepidemiology November 24 - 25, 2017 , Dubai, UAE.

Related Associations or Societies:

International Society for Pharmacoepidemiology, Center for Drug Safety and Effectiveness,  Center for Public Health and Human Rights, Center  for Health Services  and Outcomes Research, International Pharmaceutical Federation, International Society of Pharmacovigilance .

Track 6: Pharmacology :

Pharmacology  is the study of interaction of drug substances with medicinal properties in living organisms to produce a change in physiology or a function. It deals with drug discovery, research, screening, design, structural aspects, mechanism of action and development of advanced drugs. The Pharmacology may be distinguished based on the site of action of drugs viz., Biochemical pharmacology, Ethanopharmacology, Ocular pharmacology, Cardiovascular Pharmacology, Neuropharmacology, Pscychopharmacology.

Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events

8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 8th World Congress on Toxicology and Pharmacology April 13-15, 2017 Dubai, UAE; World Heart Congress May 22-24, 2017 Osaka, Japan; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala lumpur, Malaysia; 8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; April 27 - 28, 2017; 19th International Conference on Pharmacoepidemiology and Pharmacogenetics January 8 - 9, 2017,Singapore : 19th International Conference on Pharmaceutical Preformulation and Pharmacoepidemiology November 24 - 25, 2017 , Dubai, UAE.

Related Associations or Societies:

Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research AssociatesClinical Research Society, American Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry .

Track 7: Genetic epidemiology :

Genetic epidemiology is the study of the role of genetic factors and genetic  variations in determining health and disease in families and in populations, and the interplay of such genetic factors with environmental factors. Genetic epidemiology seeks to derive a statistical and quantitative analysis of how genetics work in large groups.

Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events

8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 8th World Congress on Toxicology and Pharmacology April 13-15, 2017 Dubai, UAE; World Heart Congress May 22-24, 2017 Osaka, Japan; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala lumpur, Malaysia; 8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; April 27 - 28, 2017; 19th International Conference on Pharmacoepidemiology and Pharmacogenetics January 8 - 9, 2017,Singapore : 19th International Conference on Pharmaceutical Preformulation and Pharmacoepidemiology November 24 - 25, 2017 , Dubai, UAE.

Related Associations or Societies:

International Society for Pharmacoepidemiology, Center for Drug Safety and Effectiveness,  Center for Public Health and Human Rights, Center  for Health Services  and Outcomes Research, International Pharmaceutical Federation, International Society of Pharmacovigilance

Track 8: Risk Management :

Pharma Risk Management was desgined as a set of pharmacovigilance activities and interventions designed to identify, characterise, prevent or minimise risks of  medicinal and therapeutic products including the assessment of the effectiveness of their clinical reactions, interventions and combination therapies. Drug industry need to promote companies in pharmacovigilance practice to use information technology and provide efficient softwares to implement the risk minimisation plans in drug development and manufacture . Pharmaceutical risk management monitors unlicensed, off labels and orphan drugs ,risk management labeling, regulatory decisions, legal protection, intellectual property, enforcement, marketing, and company reputation.

Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events

8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 8th World Congress on Toxicology and Pharmacology April 13-15, 2017 Dubai, UAE; World Heart Congress May 22-24, 2017 Osaka, Japan; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala lumpur, Malaysia; 8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; April 27 - 28, 2017; 19th International Conference on Pharmacoepidemiology and Pharmacogenetics January 8 - 9, 2017,Singapore : 19th International Conference on Pharmaceutical Preformulation and Pharmacoepidemiology November 24 - 25, 2017 , Dubai, UAE.

Related Associations or Societies:

Society for Clinical TrialsAssociation of Clinical ResearchThe Society of Clinical Research AssociatesClinical Research SocietyAmerican Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry .

Track 9: Adverse Drug Reactions :

 Adverse drug reactions is that unwanted harmful reaction or irritable side effect which is experienced after the administration of a drug or combination of drugs under normal conditions of use. Adverse drug reactions embrace rashes, jaundice, anemia, a decrease in the white white blood cell count, kidney damage, and nerve injury that will impair vision or hearing. Affected people is also allergic or supersensitized to the drug owing to genetic variations in the way their body metabolizes or responds to medicine. 

Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events

8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 8th World Congress on Toxicology and Pharmacology April 13-15, 2017 Dubai, UAE; World Heart Congress May 22-24, 2017 Osaka, Japan; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala lumpur, Malaysia; 8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; April 27 - 28, 2017; 19th International Conference on Pharmacoepidemiology and Pharmacogenetics January 8 - 9, 2017,Singapore : 19th International Conference on Pharmaceutical Preformulation and Pharmacoepidemiology November 24 - 25, 2017 , Dubai, UAE.

Related Associations or Societies:

International Society for Pharmacoepidemiology, Center for Drug Safety and Effectiveness,  Center for Public Health and Human Rights, Center  for Health Services  and Outcomes Research, International Pharmaceutical Federation, International Society of Pharmacovigilance

Track 10: Case Reports in Clinical Trials :

A case report is a detailed report of the signs or symptoms of a disease or diagnosis, treatment, and follow-up of an individual patient upon treatment by a pharmaceutical product. It contains a profile of the patient. Case reports can play a relevant role in medical education and provide a structure for case-based learning. Case reports may be on unexpected association between diseases, disorders or unwanted symptoms. An unexpected event in the course of observing, treating a patient, possibilities of  pathogenesis of a disease or an adverse effect.

Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events

8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 8th World Congress on Toxicology and Pharmacology April 13-15, 2017 Dubai, UAE; World Heart Congress May 22-24, 2017 Osaka, Japan; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala lumpur, Malaysia; 8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; April 27 - 28, 2017; 19th International Conference on Pharmacoepidemiology and Pharmacogenetics January 8 - 9, 2017,Singapore : 19th International Conference on Pharmaceutical Preformulation and Pharmacoepidemiology November 24 - 25, 2017 , Dubai, UAE.

Related Associations or Societies:

Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research AssociatesClinical Research Society, American Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry .

Track 11: Pharmacovigilance and its Significance  :

Pharmacovigilance plays a key role in all phases of clinical trials, including the planning, execution, data analysis and reporting of safety information and also bears an important responsibility for the expedited reporting of individual cases and safety updates required for regulatory authorities. The concept of Pharmacovigilance and its Significance enhances the impact of healthcare management on patient welfare and public health. Pharmacovigilance legislation gives an outlook on the rules and regulations to follow in Pharmacovigilance practice. The Role of pharma industries in the improvement of pharmacovigilance system is very crucial to maintain the safety data, detection and evaluation of drug safety signals through manual and medical devices reporting. Pharmacovigilance scope also deals as Ecopharmacovigilance (EPV), pharmacoenvironmentology and pharmacovigilance in herbal medicines. In addition, data from observational epidemiological studies are playing an increasingly important role.

Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events

8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 8th World Congress on Toxicology and Pharmacology April 13-15, 2017 Dubai, UAE; World Heart Congress May 22-24, 2017 Osaka, Japan; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala lumpur, Malaysia; 8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; April 27 - 28, 2017; 19th International Conference on Pharmacoepidemiology and Pharmacogenetics January 8 - 9, 2017,Singapore : 19th International Conference on Pharmaceutical Preformulation and Pharmacoepidemiology November 24 - 25, 2017 , Dubai, UAE.

Related Associations or Societies:

International Society for Pharmacoepidemiology, Center for Drug Safety and Effectiveness,  Center for Public Health and Human Rights, Center  for Health Services  and Outcomes Research, International Pharmaceutical Federation, International Society of Pharmacovigilance .

Track 12: Clinical Data Management :

Databases contain professional assessment of the potential of drugs and  permits the risk- profit analysis of medicinal products taking under consideration new and emerging information, within the context of additive data. These database offers programming of alerts for fast cases, follow-up cases and reports submission to fulfill regulative timeline compliance. Data sources of pharmacoepidemiological databases are CPRD (Clinical Practice Research Datalink), IMS Health Disease Analyzer databases,PHARMO,Vigibase and Eudravigilance. Pharmacoepidemiology research studies may involve either data collected prospectively for  the purpose of the particular study  i.e. primary data, or data that were already collected for another purpose – as part of administrative records or patient health care , which is called secondary data.

Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events

8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 8th World Congress on Toxicology and Pharmacology April 13-15, 2017 Dubai, UAE; World Heart Congress May 22-24, 2017 Osaka, Japan; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala lumpur, Malaysia; 8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; April 27 - 28, 2017; 19th International Conference on Pharmacoepidemiology and Pharmacogenetics January 8 - 9, 2017,Singapore : 19th International Conference on Pharmaceutical Preformulation and Pharmacoepidemiology November 24 - 25, 2017 , Dubai, UAE.

Related Associations or Societies:

Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research AssociatesClinical Research Society, American Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry .

Track 13: Regulatory affairs :

Regulatory affairs is developed to protect public health by controlling the safety and efficacy of medical devices and pharmaceutical drug products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines. Regulatory affairs (RA), also called government affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, banking, telecom etc.

Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events

8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 8th World Congress on Toxicology and Pharmacology April 13-15, 2017 Dubai, UAE; World Heart Congress May 22-24, 2017 Osaka, Japan; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala lumpur, Malaysia; 8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; April 27 - 28, 2017; 19th International Conference on Pharmacoepidemiology and Pharmacogenetics January 8 - 9, 2017,Singapore : 19th International Conference on Pharmaceutical Preformulation and Pharmacoepidemiology November 24 - 25, 2017 , Dubai, UAE.

Related Associations or Societies:

International Society for PharmacoepidemiologyCenter for Drug Safety and Effectiveness,  Center for Public Health and Human RightsCenter  for Health Services  and Outcomes ResearchInternational Pharmaceutical FederationInternational Society of Pharmacovigilance .

Track 14: Clinical Pharmacy :

Pharmacy practice is the field of pharmacy which involves developing the professional roles of pharmacists and is the order of drug store which includes adding to the expert parts of drug specialists. It includes Disease-state management, Clinical drug interventions, Pharmacy professional development and pharmaceutical care, pharmaceutical compounding and health psychology, patient care, drug abuse prevention, prevention of drug interactions or minimisation of adverse events and drug incompatibility and community pharmacy.

Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events

8th Global Pharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 8th World Congress on Toxicology and Pharmacology April 13-15, 2017 Dubai, UAE; World Heart Congress May 22-24, 2017 Osaka, Japan; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala lumpur, Malaysia; 8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; April 27 - 28, 2017; 19th International Conference on Pharmacoepidemiology and Pharmacogenetics January 8 - 9, 2017,Singapore : 19th International Conference on Pharmaceutical Preformulation and Pharmacoepidemiology November 24 - 25, 2017 , Dubai, UAE.

Related Associations or Societies:

Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research AssociatesClinical Research Society, American Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry .

Track 15: Diversity in Industrial Clinical Research :

The clinical trial industry is evolving in an ever growing pace with diversified and updated strategies in clinical research technologies and new clinical and experimental studies are being launched rapidly. Clinical trials play a prominent role in medicine development process, as they provide the best clinical data for the treatment of diseases and disorders. This track includes various research developments in the field of Herbal Medicines, dietary supplements and vetenary products.

Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events

8th GlobalPharmacovigilance & Drug Safety Summit, July 10-11, 2017 Jakarta, Indonesia; 8th World Congress on Toxicology and Pharmacology April 13-15, 2017 Dubai, UAE; World Heart Congress May 22-24, 2017 Osaka, Japan; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; 9th Annual Congress on Drug Formulation & Drug Design, October 19-21, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala lumpur, Malaysia; 8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; April 27 - 28, 2017; 19th International Conference on Pharmacoepidemiology and Pharmacogenetics January 8 - 9, 2017, Singapore : 19th International Conference on Pharmaceutical Preformulation and Pharmacoepidemiology November 24 - 25, 2017 , Dubai, UAE.

Related Associations or Societies:

International Society for Pharmacoepidemiology, Center for Drug Safety and Effectiveness,  Center for Public Health and Human Rights, Center  for Health Services  and Outcomes Research, International Pharmaceutical Federation, International Society of Pharmacovigilance

About the conference

ConferenceSeries Ltd is delighted and cordially welcomes you to attend the  11th International Conference on Pharmacoepidemiology and Clinical research, July 06-08, 2017 at Kuala Lumpur, Malaysia.

 

Why to Attend???

11th International Conference on Pharmacoepidemiology and Clinical research July 06-08, 2017 at Kuala Lumpur, Malaysia is organised aiming to bring together leading academic professors, scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmacoepidemiology and Clinical research. It also provides a premier interdisciplinary pavement  for Pharma, Biotech and Medical Device industries and to represent their company and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmacoepidemiology and Clinical trials and clinical research.

Pharma-epidemiology congress includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and extensive networking and B2B interactions.

ConferenceSeries Ltd Organizes 3000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals  which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members.

Mark your dates to join the critical discussions and meet the experts at Pharma-epidemiology congress, Kuala Lumpur, Malaysia to enleash Advanced Clinical research and compliance in Pharmacoepidemiologic studies in the arena of Pharmacoepidemiology.

 

Who Should Attend

Directors/Senior Directors/Executive Directors and Vice Presidents/Senior Vice Presidents/Executive Vice Presidents and Heads/Leaders/Partners of

  • CROs and CMOs
  • Clinical Research Sites
  • Pharma/Biotech and Medical Device industries
  • Hospitals, Associations

Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals along with Academicians: University Faculties like Directors, Senior Professors/Assistant Professors/ Associate Professor, Research Scholars, scientists who are related to clinical and medical research.

Clinical/Pharmaceutical and biotech industry professionals with responsibilities in:

  • Clinical Research & Development 
  • Clinical Design/ Protocol Design/ Clinical Strategy
  • Global Clinical Operations/ Clinical Outsourcing 
  • Biostatistics/Data management
  • Patient Recruitment/Enrollment 
  • Clinical Trial Management/Clinical Trial Supplies
  • Regulatory Affairs

            

Market Analysis

Market Analysis :

The global Pharmacoepidemiology and clinical research market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) of 7.5%, during the forecast period 2016 to 2021. Clinical research involves Clinical trial as a part of clinical research that follows a regulated protocol. Clinical research is primarily performed to to estimate safety and efficacy of the new developed drug. Clinical trial data is mandatory for further approval of the drug and to bring it into the market.

Why Malaysia?

The national capital and most populous city of Malaysia is Kuala Lumpur. It is amongst the fastest growing metropolitan city in South-East Asia, in terms of economy and population. Kuala Lumpur was ranked 48th amongst global cities by Foreign Policy's 2010 Global Cities Index and ranks 67th among global cities for social and economic innovation by the 2thinknow Innovation Cities Index in the year 2010.

Clinical research is one of thecore technologies to accelerate the transformation of the entire country-Malaysia into a knowledge based economy and an industrialized nation by year 2020.

The Malaysian healthcare subsector is in a state of relative infancy occupied with many small and medium-sized companies offering products and services in contract based research, tissue banking, naturally derived products, in-vitro diagnostic and orthopedic devices.

This sector is estimated to be upto worth US$ 1.37 million, and is expected to grow at a CAGR of 10.5%.

Malaysia provides opportunities for global participation and robust development in the field of biochemistry. Malaysia anticipates to attract more participation from global biotechnology and biochemistry sectors as it strives to be the preferred destination for biotechnology and biochemistry investments.

Undoubtedly, Malaysia presents a unique and ideal environment for prospective business to strategically grow and lead an innovative global nation.

The United States and Canada have the highest market share in the clinical research and clinical trials market, followed by Europe where Germany leads the market followed by Poland and Western Europe. Asia is one of the fastest growing markets. India, China, Singapore and South Korea are the major players involved in this market. The Asia-Pacific region has become an attractive destination for companies offering CTMS software. The high growth in this regional segment can be attributed to a number of factors, such as rising number of clinical trials, presence of a large number of CROs, government initiatives, increase in outsourcing of clinical trials, availability of large and diverse patient population, presence of less stringent regulatory guidelines as compared to developed nations, and cost advantages offered by various countries.

Leading companies are outsourcing their clinical trials to the APAC region due the lower cost of the clinical trials in the region as compared to the developed regions (Europe and North America).This high growth is attributed to the fact that the cost involved in performing a trial is less and the huge domain it provides in the aspect of diseases and patients.

The increasing disease burden is propelling the pharmaceutical and biotechnology industry to bring up new chemical entities into the market at a higher rate. Most companies are outsourcing the clinical trials of their newly developed drugs to various contract research organizations as this could save them the hassles of regulatory issues and patient recruitment burden from the research and development phase. Pharmacoepidemiology and Clinical research the drug to be tested for safety by different ethnic population. Due to the higher medical needs and increasing disease prevalence, developing countries are becoming a hub for clinical trial execution. Since 2006, there has been an increased number of trials registered worldwide and it is estimated to increase further in the coming years, which would contribute to the market growth.

The report identifies the different trends and key opportunities in clinical trials market, and provides the market share of major segments and geographical regions. This report provides strategic insights on industry competition, and covers key facts, business overview, service portfolio, SWOT analysis and financial analysis of leading players in the market.The major segments contributing the growth strategies in global market of Clinical research are:    

  • eClinical solution vendors
  • Clinical research organizations
  • Pharmaceutical/biopharmaceutical companies
  • Research and development (R&D) companies
  • Business research and consulting service providers
  • Medical research laboratories
  • Academic medical centers/universities/hospitals
  • Healthcare IT service providers

Pharmaceutical Societies and Associations across the world: 

  • Center for Drug Safety and Effectiveness
  • Center for Public Health and Human Rights
  • Center for Health Services and Outcomes Research
  • European federation on Pharmaceutical sciences
  • Pharmaceutical Research and Manufacturers of America
  • National Pharmaceutical Association
  • Association of Pharmacy Professionals
  • Pharmaceutical Society of Ireland
  • The Pharmaceutical Association of Israel
  • Kuwait Pharmaceutical Association
  • Pharmaceutical Society Of New Zealand
  • Pharmaceutical Association of Mauritius
  • International Pharmaceutical Federation (FIP)
  • European Pharmaceutical Union (EPU)
  • Pharmaceutical Group of the European Union (PGEU)
  • European Association of Employed Community Pharmacists in Europe (EPhEU)
  • Australian College of Pharmacy
  • Pharmaceutical Society of Australia
  • The Pharmacy Guild of Australia
  • Canadian Pharmacists Association
  • Chinese Pharmaceutical Association
  • Further information: Pharmacy in China
  • Danish Association of Pharmaconomists
  • Pharmaceutical Society of Northern Ireland
  • Royal Pharmaceutical Society (RPS)
  • National Pharmacy Association
  • American Association of Colleges of Pharmacy
  • American Pharmacists Association
  • American Society for Pharmacy Law
  • American Society of Consultant Pharmacists Foundation
  • American Society of Consultant Pharmacists (ASCP)
  • American Society of Health-System Pharmacists
  • Professional Compounding Centers of America
  • Iranian Pharmacoepidemiology
  • Drug Safety Association

Past Conference Report

Pharmacovigilance 2016

Pharmacovigilance-2016 Report

 Pharmaovigilance 2016 past Conference Report

Thanks to all of our wonderful Speakers, Conference Attendees and Sponsors; Pharmacovigilance 2016 Conference was our best ever!

The “7th International Conference and Exhibition on Pharmacovigilance”, hosted by the Conferenceseries LLC was held on August 22-24, 2016 in Fleming Hotel Wien-Westbahnhof
Neubaugürtel, 26-28,1070 Vienna, Austria. Generous response and active participation was received from the scientists, researchers and leaders from clinical, government organizations, students who made this conference as one of the most successful and productive events in 2016.

With the support and guidance of Organizing Committee Members and Editorial Board Members and astonishing presentations of all participants this prominent summit became more impressive.

Conferenceseries LLC would like to convey a great appreciation to Keynote speakers Eugenia Hong, Nathan Cummins and Alexey Skripkin.

Honourable guests and Keynote Speakers supported this event with sustainable excitement for grand success of this prominent conference. Also it is our pleasure to announce next 11th International Conference on Pharmacoepidemiology and Clinical research August 21-23, 2017 at Kaula Lumpur, Malaysia with the theme “Advanced Clinical research and compliance in Pharmacoepidemiologic studies”.

We hope your favorable support will make next conference also one more grand success.

For more details of Pharma-epidemiology Congress please visit :

http://pharmaepidemiology.pharmaceuticalconferences.com/ 


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date July 06-08, 2017

Speaker Opportunity

Supported By

Advances in Pharmacoepidemiology & Drug Safety Journal of Clinical Research & Bioethics Journal of Clinical Trials

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner